A drug-eluting stent system designed for peripheral vascular applications. It provides structural support while releasing therapeutic agents to reduce restenosis in peripheral arteries.
Manufactured by
China
Zhejiang Barty Medical Technology Co., Ltd. is a national high-tech enterprise specializing in R&D, manufacturing, and sales of vascular intervention medical devices. Established in 2015, the company operates a 1,900 sqm GMP Class 10,000 cleanroom facility. With 50+ patents, 11 Class III NMPA registrations, and 8 EU CE certificates, Barty focuses on cardiovascular and peripheral intervention products distributed across 2,000+ hospitals in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GENOSS CO., Ltd.
South Korea · 3 relevant products
Shanghai Easy-Flow Medical Tech Co., Ltd
China · 7 relevant products
Relisys Medical Devices Ltd
India · 6 relevant products
52 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 107 closest product alternatives
GENOSS CO., Ltd. · South Korea
Drug-eluting stent for peripheral vascular interventions. Designed to expand narrowed peripheral vessels and maintain vessel patency.
Shanghai Easy-Flow Medical Tech Co., Ltd · China
Peripheral drug-eluting stent system for treatment of peripheral arterial disease with anti-restenosis drug coating.
Relisys Medical Devices Ltd · India
A coronary stent coated with antiproliferative medication to reduce restenosis rates following percutaneous coronary intervention. Provides sustained drug delivery to the vessel wall over extended periods.
104 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products